MedTrace Logo

Central Serous Chorioretinopathy and Micropulse Laser Treatment

NCT06346405 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2025-09-23

No results posted yet for this study

Summary

To evaluate choroidal and choriocapillaris changes in patients with central serous chorioretinopathy, undergone sub threshold micropulse laser treatment, following any improvement with conservative therapy with Acetazolamide and/or Eplerenone

Conditions

  • Central Serous Chorioretinopathy

Interventions

OTHER

Subthreshold Micropulse Laser Treatment

Subthreshold micropulse laser treatment consists in 33 spots of 100 microns, distance among each spot of 2.50 microns, duration of 200 sec, power of 250 milliwatt (mW) duty cycle 5%.

Sponsors & Collaborators

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-31
Primary Completion
2027-05-31
Completion
2027-05-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06346405 on ClinicalTrials.gov